The Bacteroides fragilis bacteriocin which inhibits ribonucleic acid (RNA) polymerase activity had a narrow activity spectrum in vivo and only inhibited the growth of certain B. fragilis strains. In vitro the bacteriocin was not specific and inhibited RNA polymerases from widely diverse bacterial genera. RNA polymerases from rifampin-resistant strains of Bacteroides thetaiotaomicron and Clostridium acetobutylicum were resistant to the bacteriocin in vitro. Purified bacteriocin bound to partially purified RNA polymerase, and both proteins were cosedimented in a glycerol gradient. In the RNA polymerase reaction, the bacteriocin acted as a competitive inhibitor for adenosine, cytidine, and uridine 5'-triphosphates and as a noncompetitive inhibitor for guanosine 5'-triphosphate. The bacteriocin did not inhibit RNA polymerase from chicken embryos.
Mossie et al. (11) described the production of a low-molecular-weight bacteriocin by a Bacteroides fragilis strain. The mode of action of the bacteriocin is unusual in that it inhibits ribonucleic acid (RNA) synthesis, and studies with crude extracts from B. fragilis cells indicate that it prevents RNA synthesis by inhibiting RNA polymerase activity (12) . A similarity in the mode of action of the bacteriocin and rifampin was suggested by the isolation of 10 rifampinresistant mutants which all showed varying degrees of susceptibility to the bacteriocin and differed from the susceptible parent strain (12) . However, it is unlikely that the target sites for the bacteriocin and rifampin are identical, as the RNA polymerase mutants which were resistant to rifampin showed different responses to the bacteriocin. The present study was carried out to investigate the specificity and nature of the inhibition of RNA polymerase by the bacteriocin.
MATERIALS AND METHODS
Bacterial strains. The bacteriocin-producing B. fragilis Bf-1 strain and the susceptible indicator Bf-2 strain described by Mossie et al. (11) were used for the production and assay of the bacteriocin. The specificity of the bacteriocin in vivo and in vitro was tested against the following strains: Escherichia coli B, Bacillus subtilis, Vibrio alginolyticus (13) , Bacteroides thetaiotaomicron (4), B. thetaiotaomicron rif', Clostridium acetobutylicum (1), C. acetobutylicum rif, and B. fragilis Bf-2 rifr (12) .
Media and anaerobic and bacteriocin techniques. Brain heart infusion broth and agar (9) were used for bacterial growth and the production and assay of the bacteriocin as described previously (11 The pellet was suspended in 300 ml of TGED plus 0.5 M NaCl in the Omni-Mixer and blended at low speed for 5 min. The suspension was centrifuged at 6,000 rpm for 15 min, and the pellet was suspended in TGED plus 1.0 M NaCl and again blended as described above. After centrifugation at 7,000 rpm for 30 min, the supernatant (fraction II) was brought to 55c/c saturation with (NH4)2SO4. After being stirred for 30 min, the precipitate was collected by centrifugation, suspended in 20 ml of TGED buffer, and dialyzed against TGED plus 0.02 M KCI. The dialyzed enzyme preparation was diluted to 100 ml with TGED plus 0.02 M KCI and fractionated by diethylaminoethyl (DEAE)-cellulose column chromatography as described by Burgess (2) . The column (2.5 by 20 cm) was eluted stepwise with TGED plus 0.1 to 0.4 M KCI. Fractions with high specific activity were precipitated by the addition of (NH4)2SO4 (60% saturation) and dialyzed against TGED (fraction III). The degree of purification of fraction III was determined by sodium dodecyl sulfatepolyacrylamide gel electrophoresis.
Binding of "25I-labeled bacteriocin to RNA polymerase. The bacteriocin produced by B. fragilis was purified to homogeneity as described previously (11 (Fig. 1) .
Partial purification of B. fragilis RNA polymerase. The purification and specific activity of RNA polymerase from B. fragilis are shown in Table 2 . RNA polymerase after DEAEcellulose chromatography (fraction III) which had a high specific activity was analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and contained nine protein bands. The increased total activity in fraction III was presumably due to interference in the RNA polymerase assay by some component of the crude and less purifled preparations which was removed by DEAE-cellulose chromatography.
Optimum conditions for RNA polymerase activity. The optimum pH and temperature for the activity of the partially purified B.
fragilis RNA Binding of "25I-labeled bacteriocin to RNA polymerase. The purified bacteriocin which had been labeled with 125I was not sedimented by centrifugation on the glycerol gradient and remained at the top of the tube (fractions 15 to 22, Fig. 2A ). Partially purified B. fragilis RNA polymerase was sedimented in the glycerol gradient (Fig. 2B) . The RNA polymerase activity was associated with the leading edge of the protein peak (absorption at 280 nm). When the labeled bacteriocin and the partially purified RNA polymerase preparation were mixed and centrifuged together on the glycerol gradient, a large proportion of the bacteriocin cosedimented with the partially purified RNA polymerase (Fig. 2C) . The 1251 profile was similar to that obtained for the RNA polymerase activity in that it was also associated with the leading edge of the protein peak.
Kinetics of incorporation of nucleoside triphosphates. The kinetics of incorporation of nucleoside triphosphates by partially purified B. fragilis RNA polymerase into RNA in the presence and absence of purified bacteriocin (40 [Lg ml-') were determined (Fig. 3) . The bacteriocin is a noncompetitive inhibitor for the binding of guanosine 5'-triphosphate (GTP) to RNA polymerase and decreased the Vmax but did not affect the Km. The double reciprocal plots for adenosine and cytidine 5'-triphosphates (ATP and CTP) show competitive inhibition. In Fig.  3 the line which has been drawn for uridine 5'-triphosphate (UTP) involves the four points at the higher UTP concentrations and suggests that UTP shows competitive inhibition. The fifth point at the lowest UTP concentration was ignored as a considerable scatter was always obtained at this low UTP concentration and the reliability and reproducibility of the other points at the higher UTP concentrations were far greater.
DISCUSSION
In common with other bacteriocins the B. fragilis bacteriocin has a narrow activity spectrum in vivo and only inhibits the growth of certain B. fragilis strains. However, the bacteriocin in vitro is not specific and inhibits RNA polymerase from widely diverse genera. The cannot be taken as direct evidence that the curred, it would have negated our conclusions bacteriocin binds to a site on the RNA polym-from the kinetic studies. The co-sedimentation erase. However, had co-sedimentation not oc-studies therefore do add support to the sugges-440 MOSSIE h"l' AL. tion that the bacteriocin binds to the RNA polymerase. The high degree of conservation that would probably exist at this site during evolution of RNA polymerase could explain the broad spectrum of action of the B. fragilis bacteriocin in vitro. This is the first report of the partial purification of RNA polymerase with a high specific activity from the anaerobe B. fragilis. The requirements for activity of the RNA polymerase were similar to those for E. coli RNA polymerase activity (7) . Further work regarding the characterization of the RNA polymerase subunits is in progress.
